Skip to main content

Advertisement

Log in

Bladder, bowel, and sexual dysfunction in multiple sclerosis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • •The majority of patients with multiple sclerosis (MS) experience genitourinary and bowel dysfunction over the course of their illness [1,2,3 Class II].

  • •Lower extremity pyramidal signs are excellent predictors of concurrent bladder dysfunction.

  • •Constipation is the most common bowel dysfunction, which results from a range of causes including pelvic floor spasticity, decreased gastro-colic reflex, inadequate hydration, medications, immobility, poor physical conditioning, and weak abdominal muscles.

  • •Despite the advent of new therapeutic modalities, the physician and patient commonly overlook sexual dysfunction. A detailed history of the patient is crucial to determine the cause of the dysfunction. Fatigue, pain, mood disorders, spasticity, bowel, and bladder dysfunction can all interfere with normal sexual functioning, and these subjects should be explored in detail in order to plan for proper treatment.

  • •Integrated treatment plans, often in conjunction with an urologist, can lead to amelioration of symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chia YW, Fowler C, Kamm M, et al.: Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995, 242:105–108.

    Article  PubMed  CAS  Google Scholar 

  2. Bakke A, Myhr K, Gronning M, Nyland H: Bladder, bowel and sexual dysfunction in patients with multiple sclerosis-a cohort study. Scand J Urol Nephrol 1996, 179(suppl):61–66.

    CAS  Google Scholar 

  3. Hinds J, Eidelman B, Wald A: Prevalence of bowel dysfunction in multiple sclerosis: a population survey. Gastroenterology 1990, 98:1538–1542.

    PubMed  CAS  Google Scholar 

  4. Goldstein I, Siroky MB, Sax S, Krane RJ: Neurological abnormalities in multiple sclerosis. J Urol 1982, 128:541.

    PubMed  CAS  Google Scholar 

  5. Sakakibara R, Hattori T, Yasuda K, Yamanishi T: Micturitional disturbance and the pontine tegmental lesion: urodynamics and MRI analyses of vascular cases. J Neurol Sci 1996, 141:105–110.

    Article  PubMed  CAS  Google Scholar 

  6. Manante G, Melchionda D, Uncini A: Urinary retention in bilateral pontine tumor: evidence for a pontine micturition center in humans. J Neurol Neurosurg Psychiatry 1996, 61:528–536.

    Google Scholar 

  7. Kim YH, Goodman C, Omessi E, et al.: The correlation of urodynamics findings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol 1998, 159:972.

    Article  PubMed  CAS  Google Scholar 

  8. Holland NJ: Bowel management. In Multiple Sclerosis in Clinical Practice. Edited by van den Noort S, Holland NJ. New York: Demos; 1999:83. Important article on managing bowel problems in multiple sclerosis patients.

    Google Scholar 

  9. Betts CD, Jones SJ, Fowler CJ: Erectile dysfunction in multiple sclerosis: associated neurological and neurophysiological deficits, and treatment of the condition. Brain 1994, 117:1303–1310.

    Article  PubMed  Google Scholar 

  10. Lundberg PO, Hutler B: Female sexual dysfunction in multiple sclerosis: a review. Sex Dis 1996, 14:65–72.

    Article  Google Scholar 

  11. Nilvebrant L, Glas G, Jonsson A, Sparf B: The in vitro pharmacological profile of tolterodine: a new agent for the treatment of urinary incontinence. Neurourol Urodyn 1994, 13:433–435.

    Google Scholar 

  12. Cruz F, Guimaraes M, Silva C, et al.: Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamics effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997, 157:585–589.

    Article  PubMed  CAS  Google Scholar 

  13. Hilton P, Hertogs G, de Wall H, Dalm E: The use of Desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry 1983, 46:854–855.

    Article  PubMed  CAS  Google Scholar 

  14. Kinn AC, Larsson P: Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Nephrol 1990, 24:109–112.

    Article  CAS  Google Scholar 

  15. Goldstein I, Lue T, Padma-Nathan H, et al.: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998, 338:1397–1404.

    Article  PubMed  CAS  Google Scholar 

  16. Sauerwein D, Gross AJ, Kutzenberger J, Ringert RH: Wallstents in patients with detrusor-sphincter dysynergia. J Urol 1995, 154:495.

    Article  PubMed  CAS  Google Scholar 

  17. Schwartz SL, Kennelly MJ, McGuire EJ, Faeber GJ: Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. J Urol 1994, 152:99.

    PubMed  CAS  Google Scholar 

  18. Lewis R: Long term results of penile prosthetic implants. Urol Clin North Am 1995, 22:847–856.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawker, K.S., Frohman, E.M. Bladder, bowel, and sexual dysfunction in multiple sclerosis. Curr Treat Options Neurol 3, 207–213 (2001). https://doi.org/10.1007/s11940-001-0002-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-001-0002-0

Keywords

Navigation